Mediar Therapeutics
Tracy Osborne, MSN, RN, is a seasoned clinical trial leader with extensive experience in global clinical operations across various therapeutic areas, including oncology, autoimmune disorders, and rare diseases. Currently serving as the Senior Manager and Clinical Trial Lead at Mediar Therapeutics, Tracy has held previous positions as Global Clinical Trial Manager at Caribou Biosciences, where responsibilities included leading cell therapy trials, and at Telavant, overseeing a phase II trial for inflammatory bowel disease. Tracy's background encompasses roles at G1 Therapeutics, ICON plc, and PRA Health Sciences, gaining recognition as a Local Knowledge Award Recipient in 2020. Tracy holds a Master of Science in Nursing from Western Governors University and two Bachelor of Science degrees in Nursing and Psychology from The George Washington University and Georgia State University, respectively.
This person is not in any teams
This person is not in any offices
Mediar Therapeutics
Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.